zoledronic acid has been researched along with Oroantral Fistula in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
da Silva, DP; de Almeida, FC; de Araujo, ME; Marcucci, M; Marques, MM; Moreira, MS | 1 |
Ehrenfeld, M; Otto, S; Probst, F; Troeltzsch, M | 1 |
Gallego, L; Junquera, L | 1 |
Bernardeschi, P; D'Alessandro, M; Del Conte, A; Fiorentini, G; La Ferla, F; Montagnani, F; Turrisi, G | 1 |
Friedland, B; Treister, NS; Woo, SB | 1 |
Bissinger, O; Ehrenfeld, M; Kolk, A; Mast, G; Mücke, T; Otto, S; Pautke, C; Schreyer, C; Stürzenbaum, SR; Wolff, KD | 1 |
6 other study(ies) available for zoledronic acid and Oroantral Fistula
Article | Year |
---|---|
New uses for rehabilitation protocol for oral sinus communications in ARONJ patients.
Topics: Adenocarcinoma; Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clinical Protocols; Dental Prosthesis Design; Denture Design; Denture, Complete, Upper; Diphosphonates; Follow-Up Studies; Humans; Imidazoles; Jaw, Edentulous; Male; Maxilla; Neoadjuvant Therapy; Oroantral Fistula; Palatal Obturators; Patient Care Planning; Prostatic Neoplasms; Zoledronic Acid | 2014 |
Conservative management of medication-related osteonecrosis of the maxilla with an obturator prosthesis.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Debridement; Denture Bases; Denture Design; Denture, Partial, Removable; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Maxillary Diseases; Middle Aged; Oroantral Fistula; Palatal Obturators; Surgical Wound Dehiscence; Zoledronic Acid | 2015 |
Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents, Local; Bone Density Conservation Agents; Bone Neoplasms; Chlorhexidine; Debridement; Diphosphonates; Female; Humans; Hydrogen Peroxide; Imidazoles; Maxillary Diseases; Middle Aged; Mouthwashes; Multiple Myeloma; Oroantral Fistula; Osteonecrosis; Tooth Extraction; Zoledronic Acid | 2009 |
Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Maxillary Diseases; Multiple Myeloma; Oroantral Fistula; Osteonecrosis; Zoledronic Acid | 2010 |
Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphosphonates; Dry Socket; Female; Humans; Imaging, Three-Dimensional; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Oroantral Fistula; Osteonecrosis; Osteosclerosis; Pamidronate; Radiography, Dental, Digital; Radiography, Panoramic; Tooth Socket; Zoledronic Acid | 2010 |
Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Male; Maxillary Diseases; Maxillary Sinusitis; Oroantral Fistula; Pamidronate; Radiography, Panoramic; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid | 2012 |